Screening for gestational diabetes mellitus: Are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective?

Diabetes Care

Volumn 35, Issue 3, 2012, Pages 529-535

  Werner, Erika F ^a   Funai, Edmund F ^c   Pettker, Christian M ^b   Henderson, Janice ^a   Zuckerwise, Lisa ^b   Thung, Stephen F ^c   Reel, Michael ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR MODIFICATION; BIRTH INJURY; CESAREAN SECTION; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HUMAN; INTERNATIONAL ASSOCIATION OF THE DIABETES AND PREGNANCY STUDY GROUPS CRITERIA; MAJOR CLINICAL STUDY; MONITORING; MORBIDITY; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; QUALITY ADJUSTED LIFE YEAR; RATING SCALE; RISK REDUCTION; SCREENING; SENSITIVITY ANALYSIS; SHOULDER DYSTOCIA; VAGINAL DELIVERY;

COST-BENEFIT ANALYSIS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MASS SCREENING; PREGNANCY; QUALITY-ADJUSTED LIFE YEARS;

EID: 84859050930     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1643     Document Type: Article

References (38)

1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001;98:525-538
2. Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002
3. Landon MB, Mele L, Spong CY, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol 2011;117:218-224
4. Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001;75:221-228 (Pubitemid 33122077)
5. Ray JG, Vermeulen MJ, Shapiro JL, Kenshole AB; Diabetes Endocrine Pregnancy Outcome Study in Toronto. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. QJM 2001;94:347-356 (Pubitemid 32655203)
6. Horvath K, Koch K, Jeitler K, et al. Effects oftreatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 2010;340:c1395
7. Landon MB, Spong CY, Thom E, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-1348
8. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; AustralianCarbohydrate Intolerance Study inPregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2486
9. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst Rev 2009; Jul 8:CD003395
10. Thorpe LE, Berger D, Ellis JA, et al. Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990-2001. Am J Public Health 2005;95:1536-1539 (Pubitemid 41232944)
11. Ratner RE, Christophi CA, Metzger BE, et al.; Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93:4774-4779
12. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-568
13. Sibai BM, Caritis SN, Hauth JC, et al. Preterm delivery inwomenwith pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:1520-1524 (Pubitemid 32061218)
14. Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned N; Northern Diabetic Pregnancy Survey Steering Group. Trends inprevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008;115:445-452 (Pubitemid 351225158)
15. Aljohani N, Rempel BM, Ludwig S, et al. Impact of diabetes on maternal-fetal outcomes in Manitoba: Relationship with ethnic and environmental factors. Clin Invest Med 2008;31:E338-E345
16. Menacker F, Hamilton BE. Recent trends incesarean delivery in the United States. NCHS Data Brief 2010;35:1-8.
17. Macdorman MF, Kirmeyer S. The challenge of fetal mortality. NCHS Data Brief 2009;16:1-8
18. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000;38:583-637
19. Werner EF, Han CS, Pettker CM, Buhimschi CS, Copel JA, Funai EF, et al. Universal cervical length screening to prevent preterm birth: a cost-effectiveness analysis. Ultrasound Obstet Gynecol 2011;38:32-37
20. Chung A, Macario A, El-Sayed YY, Riley ET, Duncan B, Druzin ML. Cost-effectiveness of atrial of labor after previous cesarean. Obstet Gynecol 2001;97:932-941 (Pubitemid 32522491)
21. Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality oflife in diabetes. Diabetes Care 2002;25:2238-2243 (Pubitemid 41071034)
22. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost- Effectiveness Study Group, Centers for Disease Control and Prevention. JAMA 1998;280:1757-1763
23. Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-1686
24. Hernan WH, Brandle M, Zhang P, et al.; Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003;26:36-47 (Pubitemid 36928992)
25. Carroll AE, Downs SM. Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 2009;155:21-25
26. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007;167:1145-1151 (Pubitemid 46924742)
27. Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey onwillingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010; 19:422-437
28. Meltzer SJ, Snyder J, Penrod JR, Nudi M, Morin L. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG 2010;117:407-415
29. Moss JR, Crowther CA, Hiller JE, Willson KJ, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women Group. Costs and consequences oftreatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomised trial. BMC Pregnancy Childbirth 2007; 7:27
30. Kitzmiller JL, Elixhauser A, Carr S, et al. Assessment of costs and benefits of management of gestational diabetes mellitus. Diabetes Care 1998;21(Suppl. 2):B123-B130 (Pubitemid 28357044)
31. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA 1996;276:1480-1486 (Pubitemid 26398756)
32. Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol 1998;179:476-480 (Pubitemid 28413387)
33. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2007. Natl Vital Stat Rep 2010;58:1-85
34. Metzger BE, Gabbe SG, Persson B, et al.; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-682
35. Barton JR, Istwan NB, Rhea D, Collins A, Stanziano GJ. Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. Dis Manag 2006;9:236-241 (Pubitemid 44784546)
36. Culligan PJ, Myers JA, Goldberg RP, Blackwell L, Gohmann SF, Abell TD. Elective cesarean section toprevent anal incontinence and brachial plexus injuries associated with macrosomia - a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:19-28 (Pubitemid 40109750)
37. Robinson CJ, Villers MS, Johnson DD, Simpson KN. Timing of elective repeat cesarean delivery at term and neonatal outcomes: a cost analysis. Am J Obstet Gynecol 2010;202:632.e1-e6
38. Gilbert WM, Nesbitt TS, Danielsen B. The cost ofprematurity: quantification by gestational age and birth weight. Obstet Gynecol 2003;102:488-492 (Pubitemid 37311208)